Researchers Recommend Interventions as New Standard of Care for Patients with Oral Anticancer Agents
June 3rd 2020A study found that nurse-led follow-up and mobile health app leads to improved relative dose intensity, patient experiences, hospitalizations and their duration, and the rate of treatment-related grade 3 or higher toxicities.
Read More
Study Finds Remdesivir Benefits Patients with COVID-19, Results in Greater Clinical Improvement
June 2nd 2020The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.
Read More
Study: Children at Greater Risk From COVID-19 Than Previously Believed
May 26th 2020Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.
Read More